CHR | Gene | SNP | Physical position | Supposed risk allele | Frequency in cohort | OR | (95% CI) | p |
---|---|---|---|---|---|---|---|---|
3 | PPARG | rs1801282 | 12393125 | C | 0.86 | 1.11 | (0.92–1.33) | 0.27 |
3 | IGF2BP2 | rs4402960 | 185511687 | T | 0.31 | 1.27 | (1.12–1.44) | 3.05 × 10-4 |
6 | CDKAL1 | rs10946398 | 20661034 | C | 0.33 | 1.07 | (0.94–1.22) | 0.28 |
6 | CDKAL1 | rs7754840 | 20661250 | C | 0.33 | 1.06 | (0.93–1.20) | 0.41 |
6 | CDKAL1 | rs7756992 | 20679709 | G | 0.29 | 1.16 | (1.01–1.33) | 0.04 |
8 | SLC30A8 | rs13266634 | 118184783 | C | 0.69 | 1.16 | (1.01–1.32) | 0.04 |
9 | CDKN2A/2B | rs564398 | 22029547 | A | 0.58 | 1.09 | (0.96–1.23) | 0.21 |
9 | CDKN2A/2B | rs10811661 | 22134094 | T | 0.83 | 1.01 | (0.85–1.19) | 0.96 |
10 | HHEX | rs1111875 | 94462882 | G | 0.60 | 1.14 | (1.01–1.29) | 0.04 |
10 | TCF7L2 | rs7903146 | 114758349 | T | 0.27 | 1.28 | (1.13–1.46) | 1.67 × 10-4 |
16 | FTO | rs8050136 | 53816275 | A | 0.41 | 1.08 | (0.95–1.22) | 0.23 |